SNAP-8: research protocol, dosing & reconstitution
Also known as: Acetyl octapeptide-3
Quick answer
What is SNAP-8?
SNAP-8 is a topical cosmetic peptide — eight amino acids that mimic the tip of SNAP-25, a protein muscles need to receive the ‘contract’ signal. Formulated into creams at tiny concentrations, it is studied for softening expression lines. It is applied to skin, never injected, and the peer-reviewed evidence is mostly for its shorter sibling, Argireline.
What SNAP-8 is
SNAP-8 (INCI name acetyl octapeptide-3) is the eight-amino-acid extension of Argireline (acetyl hexapeptide-8), the best-known ‘Botox-like’ cosmetic peptide. Both copy the N-terminal end of SNAP-25, one of the three SNARE proteins that dock neurotransmitter vesicles at the junction between nerve and muscle.
It is a cosmetic ingredient, not an injectable research compound: it arrives as a lyophilizedLyophilizedFreeze-dried. Peptides are shipped as a lyophilized powder ('puck') because the dry form is far more stable than a solution. It must be reconstituted before use in research.See glossary → powder or a 0.05% stock solution and is dissolved into a serum or cream base at parts-per-million levels. It is in this library because vendors sell it alongside injectables, and the math is different enough to get wrong.
Mechanism of action
The mechanism was worked out for Argireline. In vitro it inhibits assembly of the SNARE complex and reduces catecholamine release from chromaffin cells; in ten healthy women, an emulsion containing 10% Argireline reduced wrinkle depth by up to 30% after 30 days, with no primary irritation or oral toxicity [1].
A later randomized, placebo-controlled trial in Chinese subjects applied 10% Argireline around the eyes twice daily for four weeks and found a significant improvement in peri-orbital wrinkles measured by silicone replica [2]. Those two studies are the human evidence base for the whole neurotransmitter-inhibiting peptide class.
SNAP-8 itself adds two residues to Argireline. The claim that it is more potent comes from the manufacturer's in vitro data, which is not peer-reviewed. Reviews of cosmeceutical peptides list it in the same class and note that getting through the stratum corneum is the limiting factor for all of them [3][4].
What researchers study SNAP-8 for
- Neurotransmitter-inhibiting (‘Botox-like’) cosmeceutical peptides
- SNARE complex assembly and vesicle docking
- Expression-line (dynamic wrinkle) models
- Topical peptide penetration and formulation science
What dose of SNAP-8 do researchers use?
Research literature commonly references doses of 15–50 ppm (0.0015–0.005%) in a finished topical formula — 3–10% of a 0.05% stock solution. This is not a recommendation — the table below summarizes protocols as they appear in published literature and trial designs.
| Context | Dose | Frequency | Duration |
|---|---|---|---|
| Argireline clinical studies [1][2] | 10% Argireline solution in an emulsion (≈50 ppm peptide) | Twice daily, topical | 30 days / 4 weeks |
| SNAP-8 formulation reference (manufacturer data) | 3–10% of a 0.05% stock solution → 15–50 ppm | Twice daily, topical | 4–12 weeks referenced |
← Swipe to see the full table
Half-life and dosing timing
Half-life: Not applicable — topical; not characterised. Route referenced in research: Topical only (research). There is no half-lifeHalf-lifeHow long it takes for half of a compound to be eliminated from the body. Half-life determines how often researchers dose a compound in protocols.See glossary → to plan around — the peptide acts locally where it is applied, and the trials used a simple twice-daily schedule [1][2]. Visible change in the Argireline studies took four weeks; expect the same order of time, not days.
Titration: start low, go slow
Not applicable in the injectable sense. Formulators start at the low end (15 ppm) and only move up if the formula is tolerated, because irritation from the cream base is more common than any effect of the peptide.
Skip the SNAP-8 math
Enter vial size, water volume, and target dose — the free calculator returns concentration, injection volume, and exact U-100 syringe units.
How is SNAP-8 reconstituted?
| Vial size | BAC water | Concentration | Worked example |
|---|---|---|---|
| 10 mg | 20 mL distilled water (not BAC water) | 0.05% stock (500 ppm) | Use 3–10% of this stock in a serum → 15–50 ppm final |
| 10 mg | 10 mL distilled water | 0.1% stock (1,000 ppm) | Use 1.5–5% of this stock → 15–50 ppm final |
Topical peptides are diluted, not reconstitutedReconstitutionThe process of mixing a freeze-dried (lyophilized) peptide powder with bacteriostatic water to create a solution of known concentration.See glossary → for injection. Dissolve a 10 mg vialVialThe small sealed glass container peptides are supplied in, topped with a rubber septum that a syringe needle can pass through.See glossary → in 20 mL of distilled water: 10 mg ÷ 20 mL = 0.5 mg/mL = 0.05%, the standard commercial stock strength. Adding 3 mL of that stock to 27 mL of serum base (10% of the formula) gives 0.005% peptide — 50 ppm — the concentration the Argireline trials used [1][2]. Bacteriostatic waterBAC water (bacteriostatic water)Sterile water containing 0.9% benzyl alcohol, which suppresses bacterial growth. It is the standard diluent used to reconstitute lyophilized peptides for multi-dose research vials.See glossary → is unnecessary here, and its benzyl alcohol can irritate skin.
New to the process? Read the full step-by-step reconstitution guide.
How long does reconstituted SNAP-8 last?
Lyophilized: refrigerated or frozen, dry and dark. Stock solution: refrigerate and use within a few weeks; the finished cream lasts only as long as its preservative system does. Keep both out of direct sunlight — peptides degrade with heat and UV.
What is SNAP-8 stacked with in research?
Commonly formulated with GHK-Cu (studied for collagen and remodelling rather than muscle signalling) and with Argireline itself; the three cover different mechanisms and are often referenced together in cosmeceutical reviews [3]. It has no role in any injectable protocol.
Side effects observed in research
Mild redness or irritation at the application site is the only effect reported, and it is usually the vehicle rather than the peptide. Argireline showed no oral toxicity or primary irritation in the original study [1]. Research-grade powder is not a finished cosmetic and is sold as Research Use OnlyRUO (Research Use Only)A regulatory classification meaning a product is sold strictly for laboratory research and is not approved, labeled, or intended for human or veterinary use.See glossary →.
- Mild redness or irritation at the application site
- Very few effects reported — topical peptides penetrate poorly
Source in Canada
COA-documented research compounds, sourced from Canada.
RegenBioSignals →Referral partner — we may earn a commission.
Frequently asked questions
Is SNAP-8 injected like other peptides?
No — it is a topical cosmetic ingredient, dissolved into creams and serums at parts-per-million concentrations. Injecting it has no basis in the literature and no rationale: it is designed to act at the nerve–muscle junctions just under the skin surface.
How does SNAP-8 differ from Argireline?
SNAP-8 is Argireline with two extra amino acids (an octapeptide instead of a hexapeptide), copying more of SNAP-25. The manufacturer reports higher in vitro activity; the peer-reviewed human trials are of Argireline [1][2], so those are the numbers this page uses.
What concentration is used?
The Argireline trials used a 10% solution in the final emulsion, about 50 ppm of actual peptide [1][2]. SNAP-8 is referenced at 15–50 ppm — 3–10% of a 0.05% stock. Going above that adds cost, not effect.
Does it work like Botox?
It targets the same step — acetylcholine release at the neuromuscular junction — but by competing with a protein rather than cleaving it, and only to the depth a topical can reach. The measured effect in trials was a reduction in wrinkle depth of up to 30% over a month [1], not paralysis.
Related research peptides
Melanotan II
A lab-made, longer-lasting version of the tanning hormone α-MSH, studied for skin pigmentation without UV and, separately, for sexual arousal — PT-141 was derived from it.
Healing & RecoveryBPC-157
A synthetic peptide fragment studied for tissue repair, tendon/ligament and gut healing in animal research.
Healing & RecoveryTB-500
A synthetic version of a region of Thymosin Beta-4, studied for cell migration, angiogenesis and tissue repair.
Browse all Cosmetic peptides or start with the beginner’s guide to research peptides.
References
- 1.Blanes-Mira C, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002. PubMed ↗
- 2.Wang Y, et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013. PubMed ↗
- 3.Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci. 2009. PubMed ↗
- 4.Errante F, et al. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem. 2020. PubMed ↗